These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1664824)

  • 1. Assessment of adverse events during drug development: experience with temafloxacin.
    Norrby SR; Pernet AG
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():111-9. PubMed ID: 1664824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    Pernet AG
    Am J Med; 1991 Dec; 91(6A):162S-165S. PubMed ID: 1662888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of fluoroquinolones.
    Norrby SR; Lietman PS
    Drugs; 1993; 45 Suppl 3():59-64. PubMed ID: 7689453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of uncomplicated urinary tract infections with temafloxacin.
    Iravani A
    Am J Med; 1991 Dec; 91(6A):124S-128S. PubMed ID: 1662882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of organ-specific toxicity of temafloxacin in animals and humans.
    Krasula RW; Pernet AG
    Am J Med; 1991 Dec; 91(6A):38S-41S. PubMed ID: 1662894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.
    Sörgel F; Mahr G; Granneman GR; Stephan U; Nickel P; Muth P
    Clin Pharmacokinet; 1992; 22 Suppl 1():65-74. PubMed ID: 1319873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G; Scorer HJ; Carnegie CM
    J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temafloxacin syndrome: review of 95 cases.
    Blum MD; Graham DJ; McCloskey CA
    Clin Infect Dis; 1994 Jun; 18(6):946-50. PubMed ID: 8086558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
    Chodosh S
    Chest; 1991 Dec; 100(6):1497-502. PubMed ID: 1659975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The withdrawal of temafloxacin. Are there implications for other quinolones?
    Finch RG
    Drug Saf; 1993 Jan; 8(1):9-11. PubMed ID: 8385956
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of temafloxacin on the pharmacokinetics of theophylline.
    Ruff F; Santais MC; Callens E; Chauvin JP; Hazebroucq J
    Am J Med; 1991 Dec; 91(6A):76S-80S. PubMed ID: 1662899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR; Braeckman R; Kraut J; Shupien S; Craft JC
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2345-51. PubMed ID: 1666497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temafloxacin in humans after single oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1991 Mar; 35(3):436-41. PubMed ID: 2039194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile of grepafloxacin compared with other fluoroquinolones.
    Stahlmann R; Schwabe R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():83-92. PubMed ID: 9484877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects prompt withdrawal of temafloxacin.
    Clin Pharm; 1992 Sep; 11(9):747, 750. PubMed ID: 1325891
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of cimetidine on the pharmacokinetics of temafloxacin.
    Sörgel F; Granneman GR; Stephan U; Locke C
    Clin Pharmacokinet; 1992; 22 Suppl 1():75-82. PubMed ID: 1319874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone toxicities. An update.
    Lietman PS
    Drugs; 1995; 49 Suppl 2():159-63. PubMed ID: 8549287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety profile of the fluoroquinolones.
    Bertino J; Fish D
    Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of temafloxacin in human scalp hair as an index of drug exposure.
    Uematsu T; Kondo K; Yano S; Yamaguchi T; Umemura K; Nakashima M
    J Pharm Sci; 1994 Jan; 83(1):42-5. PubMed ID: 8138908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.